URIN D/S- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate tabl

Nazione: Stati Uniti

Lingua: inglese

Fonte: NLM (National Library of Medicine)

Principio attivo:

Methenamine (UNII: J50OIX95QV) (Methenamine - UNII:J50OIX95QV), SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN) (Sodium Cation - UNII:LYR4M0NH37), Phenyl Salicylate (UNII: 28A37T47QO) (Phenyl Salicylate - UNII:28A37T47QO), Methylene Blue (UNII: T42P99266K) (METHYLENE BLUE CATION - UNII:ZMZ79891ZH), Hyoscyamine Sulfate (UNII: F2R8V82B84) (Hyoscyamine - UNII:PX44XO846X)

Commercializzato da:

Llorens Pharmaceutical International Division

INN (Nome Internazionale):

Methenamine

Composizione:

Methenamine 81.6 mg

Via di somministrazione:

ORAL

Tipo di ricetta:

PRESCRIPTION DRUG

Indicazioni terapeutiche:

Indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures. Hypersensitivity to any of the ingredients is possible. Risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). A dependence on the use of URIN D/S has not been reported and due to the nature of its ingredients, abuse of URIN D/S is not expected.

Dettagli prodotto:

URIN D/S is a oval, purple tablet embossed with LLORENS on one side, available in bottles of 100 tablets NDC 54859-701-10 and professional sample bottles of 4 tablets NDC 54859-701-04.

Stato dell'autorizzazione:

unapproved drug other

Scheda tecnica

URIN D/S- METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE,
PHENYL SALICYLATE,
METHYLENE BLUE, AND HYOSCYAMINE SULFATE TABLET
LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
URIN D/S
RX ONLY
Urinary antiseptic
NDC 54859-701-10
DESCRIPTION
EACH TABLET CONTAINS:
Methenamine.............................81.6 mg
Sodium Biphosphate..................40.8 mg
Phenyl Salicylate.......................36.2 mg
Methylene Blue..........................10.8 mg
Hyoscyamine Sulfate...................0.12 mg
INACTIVE INGREDIENTS: Carbopol 934P, magnesium stearate,
microcrystalline cellulose, sodium starch
glycolate, dicalcium phosphate, polydextrose, hypromellose, D&C Red
#27, titanium dioxide, FD&C
Blue #2, triacetin, FD&C Red #40, macrogol, talc.
METHENAMINE. [100-97-0] 1,3,5,7-Tetraazatricyclo [3.3.1.-1 3,7]
decane; hexamethylenetetramine;
HMT; HMTA; hexamine; 1,3,5,7-tetraazaadamantane hexamethylenemine;
Uritone; Urotropin.
C6H12N4; mol wt 140.19; C 51.40%, H 8.63%, N 39.96%. Methenamine
(hexamethylenetetramine)
exists as colorless, lustrous crystals or white crystalline powder.
Its solutions are alkaline to litmus.
Freely soluble in water, soluble in alcohol and in chloroform.
SODIUM BIPHOSPHATE. [7558-80-7] Phosphoric acid sodium salt (1:1);
Sodium biphosphate;
sodium dihydrogen phosphate; acid sodium phosphate; monosodium
orthophosphate; primary sodium
phosphate; H2NaO4P; mol wt 119.98, H 1.68%, Na 19.16%, O 53.34%, P
25.82%. Monohydrate, white,
odorless slightly deliquesce crystals or granules. At 100° C loses
all its water; when ignited it
converts to metaphosphate. It is freely soluble in water and
practically insoluble in alcohol. The
aqueous solution is acid. pH of 0.1 molar aqueous solution at 25° C:
4.5.
PHENYL SALICYLATE. [118-55-8] 2-Hydroxybenzoic acid phenyl ester;
Salol. C13H10O3; mol wt
214.22, C 72.89%, H 4.71%,